Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. University Medical Center Hamburg-Eppendorf

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The University Medical Center Hamburg-Eppendorf (UKE) is the largest hospital in Hamburg, Germany, and serves as the primary teaching hospital for the University of Hamburg. Founded in 1889, it is recognized as one of the most modern and leading medical facilities in Europe, integrating patient care, medical research, and teaching under a fully digital infrastructure

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Human-provided. Hospital
Source: Trial-derived.
128Total Trials
Source: Trial-derived.
45Recruiting Trials
Source: Trial-derived.
46Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
207Unique Conditions
Source: Trial-derived.
147Unique Sponsors

Conditions

Source: Trial-derived. Airway Management (10)Source: Trial-derived. Multiple Myeloma (5)Source: Trial-derived. Cervical Cancer (3)Source: Trial-derived. Neoplasms (3)Source: Trial-derived. AIDS (2)Source: Trial-derived. Airway Complication of Anesthesia (2)Source: Trial-derived. Atopic Dermatitis (2)Source: Trial-derived. Cardiovascular Disease (2)

Sponsors

Source: Trial-derived. Universitätsklinikum Hamburg-Eppendorf (49)Source: Trial-derived. Boston Scientific Corporation (5)Source: Trial-derived. Celgene (4)Source: Trial-derived. Hannover Medical School (4)Source: Trial-derived. Abbott Medical Devices (3)Source: Trial-derived. Charite University, Berlin, Germany (3)Source: Trial-derived. Deutsche Krebshilfe e.V., Bonn (Germany) (3)Source: Trial-derived. German Federal Ministry of Education and Research (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Participant mobile study app (eDiary/ePRO)
Source: AI-inferred. Tumour BRAF V600 mutation testing